Metformin, a drug prescribed to tens of millions of people with type 2 diabetes, is producing measurable shifts in molecular ...

Lung transplant for stage IV lung cancer achieved 100% one-year survival in 17 NSCLC patients in a landmark JAMA study from ...

Millions of adults who take statins to lower their cholesterol risk have been warned about side effects ranging from muscle ...

TriCares announced today that it enrolled the first patient in its TRICURE US FDA investigational device exemption (IDE) ...

( (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced positive results from the FB102 double-blind placebo-controlled ...

Antiamyloid drugs clear amyloid plaques and modestly slow cognitive decline in patients with Alzheimer’s disease, but whether ...

Poison control calls involving semaglutide (Ozempic and Wegovy) soared after the drug was approved for weight management, ...

(Nasdaq: IONS) and partner AstraZeneca today announced that the CARDIO-TTRansform Phase 3 trial for eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) did not meet ...

A wave of cannabis-related research published in 2026 has examined the plant’s potential impact on pain, cancer, neurological ...

Summary: Researchers demonstrated that a ketogenic diet, which shifts the body away from glucose and toward fat-derived ketones for fuel, induces rapid metabolic improvements and alleviates persistent ...

Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the ...

Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the ...